欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Eurifel RCP FeLV
适用类别Veterinary
治疗领域
通用名/非专利名称vaccine against feline viral rhinotracheitis, calicivirosis, panleucopenia and leukaemia in cats
活性成分canarypox virus expressing feline leukemia virus, live;feline calicivirus, strain 255, inactivated;feline panleucopenia virus, strain PLI IV, live;feline rhinotracheitis virus, strain C27, antigen
产品号EMEA/V/C/000067
患者安全信息No
许可状态Withdrawn
ATC编码QI06AH
是否额外监管Nei
是否仿制药或hybrid药物Nei
是否生物类似药Nei
是否附条件批准Nei
是否特殊情形Nei
是否加速审评Nei
是否罕用药Nei
上市许可日期2002/03/08
上市许可开发者/申请人/持有人Merial
人用药物治疗学分组
兽用药物治疗学分组Immunologicals for felidae
欧盟委员会决定日期2004/07/23
修订号8
治疗适应症Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia. Stimulates active immunity against feline rhinotracheitis virus, feline calicivirus, feline panleucopenia virus and feline leukaemia virus. The feline leukaemia vaccine strain is a recombinant canarypox virus expressing the env and gag genes of FeLV-A. Under field conditions, only sub-group A is infective and immunisation against subgroup A provides full protection against A, B and C. After inoculation, the virus expresses the protective proteins, but does not replicate in the cat. As a consequence, the vaccine induces an immune status against feline leukaemia virus.
适用物种Cats
兽用药物ATC编码QI06AH
首次发布日期2004/07/23
最后更新日期2004/07/23
产品说明书
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/eurifel-rcp-felv
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase